ARCHIVES

In Brief: AC Committee Picks Seffrin for Executive VP; Charles Wilson Names to NCAB; 5 Leave Board

This article is from The Cancer Letter archive.

Vol. 18 No. 20 | May 15, 1992

Download PDF Visit The Full Archive

Related Articles

NCI advisors seek comment on clinical trials system, until Jan. 15.

December 10, 2004

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

In Brief: NCI awards center Grant to Cancer Institute of New Jersey; Researcher Win Honors

April 4, 1997

Proposed Regulations for Center Grants In Federal Register

October 29, 1976

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

October 18, 2013

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006